Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma.

Saved in:
Bibliographic Details
Title: Combination of rituximab, cyclophosphamide, and vincristine induces complete hematologic remission of splenic marginal zone lymphoma.
Authors: Arcaini L; Division of Hematology, IRCCS Policlinico San Matteo, University of Pavia, Italy. luca.arcaini@unipv.it, Orlandi E, Scotti M, Brusamolino E, Passamonti F, Burcheri S, Colombo N, Vanelli L, Sbalzarini G, Lazzarino M
Source: Clinical lymphoma [Clin Lymphoma] 2004 Mar; Vol. 4 (4), pp. 250-2.
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Cancer Information Group Country of Publication: United States NLM ID: 100898741 Publication Model: Print Cited Medium: Print ISSN: 1526-9655 (Print) Linking ISSN: 15269655 NLM ISO Abbreviation: Clin Lymphoma Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first